HRGN (Harvard Apparatus Regenerative Technology) Total Receivables: $0.02 Mil (As of Mar. 2026)


HRGN Harvard Apparatus Regenerative Technology Inc HRGN
27 GF Score
Price $1.05
GF Value $5.34
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Harvard Apparatus Regenerative Technology Total Receivables?

Harvard Apparatus Regenerative Technology HRGN 27 Total Receivables is $0.02 Mil as of Mar. 2026. GuruFocus rates HRGN with a GF Score™ of 27/100 and a GF Value™ of $5.34 (Possible Value Trap). The stock has 2 warning signs investors should review.

Harvard Apparatus Regenerative Technology's Total Receivables for the quarter that ended in Mar. 2026 was $0.02 Mil.

Harvard Apparatus Regenerative Technology Total Receivables Related Terms

Harvard Apparatus Regenerative Technology Total Receivables Historical Data

* Premium members only.

The historical data trend for Harvard Apparatus Regenerative Technology's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Harvard Apparatus Regenerative Technology Total Receivables Chart

Harvard Apparatus Regenerative Technology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.23 0.02

Harvard Apparatus Regenerative Technology Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.01 0.00 0.02 0.02
HRGN
27GF Score
Harvard Apparatus Regenerative Technology Inc HRGN
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Harvard Apparatus Regenerative Technology Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of $0.02 Mil mean?
Harvard Apparatus Regenerative Technology (HRGN) has a Total Receivables of $0.02 Mil as of Mar. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Harvard Apparatus Regenerative Technology and its competitors.
Is Harvard Apparatus Regenerative Technology's Total Receivables too high?
Harvard Apparatus Regenerative Technology's current Total Receivables is $0.02 Mil. Overall, Harvard Apparatus Regenerative Technology has a GF Score™ of 27/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Harvard Apparatus Regenerative Technology's Total Receivables compare to DTEAF and STCB?
Harvard Apparatus Regenerative Technology's Total Receivables of $0.02 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Consumer Packaged Goods company?
A good Total Receivables depends on the Consumer Packaged Goods industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Harvard Apparatus Regenerative Technology and its competitors. Harvard Apparatus Regenerative Technology's current Total Receivables is $0.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Harvard Apparatus Regenerative Technology stock overvalued right now?
Based on GuruFocus' analysis, Harvard Apparatus Regenerative Technology (HRGN) is currently considered Possible Value Trap. The stock's GF Value™ is $5.34, compared to a current price of $1.05 — trading 80.3% below its estimated fair value. The current Total Receivables is $0.02 Mil. Harvard Apparatus Regenerative Technology's overall GF Score™ is 27/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Harvard Apparatus Regenerative Technology (HRGN), the current Total Receivables is $0.02 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Harvard Apparatus Regenerative Technology (HRGN) Overvalued in 2026?

Based on GuruFocus' analysis, Harvard Apparatus Regenerative Technology stock appears to be undervalued. The current stock price of $1.05 is trading 80.3% below its estimated GF Value™ of $5.34. GuruFocus considers Harvard Apparatus Regenerative Technology to be Possible Value Trap.

Key valuation signals for HRGN:

  • Total Receivables: $0.02 Mil
  • GF Value™: $5.34 vs. price of $1.05 (80.3% below fair value)
  • GF Score™: 27/100 with 2 warning signs

No single metric tells the full story. See the HRGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Harvard Apparatus Regenerative Technology Business Description

Address 84 October Hill Road, Suite 11, Holliston, MA, USA, 01746
Harvard Apparatus Regenerative Technology is a clinical-stage biotechnology company focused on the development of regenerative medicine treatments for disorders of the gastrointestinal system and other organs that result from cancer, trauma, or birth defects. Its technology is based on a proprietary cell-therapy platform that uses a patient's own stem cells to regenerate and restore function to damaged organs. The Company has two operating and reportable segments: Regenerative Biotech, focused on the development of regenerative medicine treatments with operations currently in the United States, and Consumer Health Products relating to consumer health products with operations currently in Asia.
27GF Score

Get the complete analysis for HRGN

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.05
Price
$5.34
GF Value